Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/KEROS-THERAPEUTICS-INC-106001599/news/Keros-Therapeutics-gibt-FDA-Fast-Track-Zulassung-fur-KER-050-bei-myelodysplastischen-Syndromen-mit-46202132/?utm_source=whatsapp&utm_medium=social&utm_campaign=share